Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis

Pediatr Infect Dis J. 2009 Aug;28(8):748-50. doi: 10.1097/INF.0b013e31819bc491.

Abstract

Treatment of extensively drug-resistant tuberculosis (XDR-TB) is a challenge. We describe a young child with pulmonary XDR-TB who did not respond to an aggressive multidrug-resistant TB treatment regimen, but was cured with linezolid in combination with other reserve antituberculous drugs. No serious adverse events were observed during 19 months of treatment for XDR-TB.

Publication types

  • Case Reports

MeSH terms

  • Acetamides / administration & dosage*
  • Acetamides / adverse effects
  • Antitubercular Agents / administration & dosage*
  • Drug Administration Schedule
  • Drug Resistance, Multiple, Bacterial*
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / microbiology
  • Female
  • Humans
  • Infant
  • Linezolid
  • Oxazolidinones / administration & dosage*
  • Oxazolidinones / adverse effects
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Acetamides
  • Antitubercular Agents
  • Oxazolidinones
  • Linezolid